A cutting edge therapeutic for modern regenerative medicine. Our recombinant protein reverses the most common complication after a myocardial infarction: scar tissue formation that weakens the heart and leads to progressive heart failure.
Investors 1
| Date | Name | Website |
| - | MBC BioLab... | mbcbiolabs... |
Mentions in press and media 1
| Date | Title | Description |
| 28.03.2022 | Explore Innovations in Cardiac Regenerative Therapies on Advancements TV Series | Today’s standard of care for treating acute MI saves lives and limits tissue damage, but it cannot restore lost heart muscle, reduce infarct scar size or prevent subsequent progression to heart failure... JUPITER, Fla. (PRWEB) March 28, 202... |